-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$42.40-13.79% Downside
Twist Bioscience Corporation Frequently Asked Questions
-
What analysts cover Twist Bioscience Corporation?
Twist Bioscience Corporation has been rated by research analysts at Robert W. Baird, Guggenheim, Goldman Sachs, Barclays, Evercore ISI in the past 90 days.